Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Breast Neoplasms 8Rectal Neoplasms 5Lung Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma Of Esophagus 4Colonic Neoplasms 3Central Nervous System Neoplasms 3Breast Neoplasms, Male 3Brain Neoplasms 3Sarcoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Osteosarcoma 2Lymphoma 2Head and Neck Neoplasms 2Glioblastoma 2Breast Carcinoma In Situ 2Vomiting 1Teratoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Peritoneal Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Nausea 1Medulloblastoma 1

Interventions

Temozolomide 53Bevacizumab 45Radiotherapy 28Radiosurgery 21Carboplatin 14Erlotinib Hydrochloride 11Radiation 10pembrolizumab 9Magnetic Resonance Spectroscopy 9Etoposide 9Vorinostat 8Trastuzumab 8Irinotecan 8Sunitinib 7Sorafenib 7Radiotherapy, Intensity-Modulated 7Lomustine 7Lapatinib 7Capecitabine 7dabrafenib 6Ipilimumab 6Imatinib Mesylate 6Cyclophosphamide 6Sirolimus 5Hydroxyurea 5Everolimus 5Bortezomib 5temsirolimus 4cabozantinib 4binimetinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Brain Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT00047320 2018-02-14

Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
104 enrolled 12 charts
CNS

Brain Neoplasms, Teratoma, Central Nervous System Neoplasms

NCT00302159 2016-08-18

Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 14 charts
CNS

Brain Neoplasms, Glioblastoma

NCT00036569 2012-02-13

A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
32 enrolled 12 charts
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡